Caricamento...
Targeting glycogen synthase kinase-3 (GSK-3) in the treatment of Type 2 diabetes
BACKGROUND: In spite of its rather specific name, glycogen synthase kinase-3 (GSK-3) is an eclectic cellular regulator that modulates an array of processes from nuclear transcription, to neurological functions and metabolism. The enzyme is also a focal point for diverse signaling pathways that act t...
Salvato in:
| Pubblicato in: | Expert Opin Ther Targets |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2008
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4485462/ https://ncbi.nlm.nih.gov/pubmed/18781825 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/14728222.12.10.1265 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|